drugset

drugset / Trial / NCT00642798

An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)

NCT00642798 ↗

Phase 1 Completed 16 enrolled Merck Sharp & Dohme LLC

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To support the registration of sitagliptin 100mg in china.

Timeline

Start: 2008-03
Primary completion: 2008-03
Completion: 2008-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sitagliptin	Small molecule	100 mg	—

Indications